262 - HIV/STD Cases

Saturday, October 22, 2022

3:15 PM – 4:30 PM US ET

Location: 145 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Interactive Moderator(s)

Meena Ramchandani, MD, MPH

Associate Professor
University of Washington

Disclosure(s): Gilead: Stocks/Bonds (Ongoing); Merck Inc: Stocks/Bonds (Ongoing)
Jason Zucker, MD, MS

Assistant Professor of Medicine
Internal Medicine and Pediatrics
Columbia University Irving Medical Center
New York, NY, United States

Disclosure(s): No financial relationships to disclose

Slides

Panelist(s)

Joseph Cherabie, MD, MSc

Assistant Professor
Washington University St. Louis
St. Louis, MO, United States

Disclosure(s): Roche Diagnostics: Honoraria (Ongoing)
Philana Liang, PAC, MPH

Physician Assistant
Washington University
St. Louis, MO, United States

Disclosure(s): No financial relationships to disclose
Candice McNeil, MD, MPH

Associate Professor
Wake Forest School of Medicine
Winston Salem, NC, United States

Disclosure(s): Becton Dickinson (BD): Grant/Research Support (Terminated); Biomedical Advanced Research and Development Authority/GSK: Grant/Research Support (Ongoing); Centers for Disease Control and Prevention (CDC): Grant/Research Support (Ongoing); Gilead: Grant/Research Support (Ongoing); Hologic: Grant/Research Support (Ongoing); Lupin: drug for susceptibility testing and treatment (Terminated); National Association of County and City Health Officials: Grant/Research Support (Terminated); National Institutes of Health: Grant/Research Support (Ongoing), paid to her employer, Wake Forest University School of Medicine (Ongoing)
Rodrigo Burgos, PharmD, MPH

Assistant Professor
Pharmacy Practice
University of Illinois at Chicago
Chicago, Illinois, United States

Disclosure(s): Clinical Care Options: Speaker/lecturer (Ongoing); Janssen Vaccines & Prevention BV: Clinical trial sponsor (Ongoing); OptumRx: Advisor/Consultant (Ongoing)

Disclosure(s):

Meena Ramchandani, MD, MPH: Gilead: Stocks/Bonds (Ongoing); Merck Inc: Stocks/Bonds (Ongoing)

Jason Zucker, MD, MS: No financial relationships to disclose

Joseph Cherabie, MD, MSc: Roche Diagnostics: Honoraria (Ongoing)

Philana Liang, PAC, MPH: No financial relationships to disclose

Candice J. McNeil, MD, MPH: Becton Dickinson (BD): Grant/Research Support (Terminated); Biomedical Advanced Research and Development Authority/GSK: Grant/Research Support (Ongoing); Centers for Disease Control and Prevention (CDC): Grant/Research Support (Ongoing); Gilead: Grant/Research Support (Ongoing); Hologic: Grant/Research Support (Ongoing); Lupin: drug for susceptibility testing and treatment (Terminated); National Association of County and City Health Officials: Grant/Research Support (Terminated); National Institutes of Health: Grant/Research Support (Ongoing), paid to her employer, Wake Forest University School of Medicine (Ongoing)

Rodrigo M. Burgos, PharmD, MPH: Clinical Care Options: Speaker/lecturer (Ongoing); Janssen Vaccines & Prevention BV: Clinical trial sponsor (Ongoing); OptumRx: Advisor/Consultant (Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss STI cases in the context of HIV infection;
describe new strategies to prevent HIV and STD coinfections;
discuss new STI treatment guidelines